Parsippany, NJ, United States
Ferring Pharmaceuticals Inc recalls
4 recalls recorded since 2018, most recently on 12 June 2023. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls4
Ongoing (FDA)0
Terminated or completed4
Class I (FDA)1
Terminated Class II Drugs
- Recall started
- 12 June 2023
- Terminated
- 5 August 2024
- Reason
- cGMP deviations: potential for Microbial Contamination of Non-Sterile Products
- Distribution
- USA Nationwide
- Initiated
- N/A
- Recall number
- D-0879-2023
- Endometrin (progesterone) Vaginal Insert 100mg, packaged in a carton of 21 vaginal inserts with 21 disposable vaginal applicators, Manufactured for: Ferring Pharmaceuticals Inc., Parsippany, NJ NDC# 55566-6500-03
Terminated Class II Drugs
- Recall started
- 11 March 2021
- Terminated
- 7 June 2023
- Reason
- Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.
- Distribution
- Nationwide in the USA
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-0318-2021, D-0317-2021
- ZOMA-Jet 10 Demonstration Kit, Needle-free delivery device for use with ZOMACTON (somatropin) for injection 10 mg vial, ZOMA-Jet 10 Demonstration Kit contains -ZOMA-Jet 10 device - 7 Needle-Free Head A's - 1 Carrying Cas
- ZOMA-Jet 5 Demonstration Kit, Needle-free delivery device for use with ZOMACTON (somatropin) for injection 5mg vial, Rx only, ZOMA-Jet 5 Demonstration Kit contains -ZOMA-Jet 5 device - 5 Needle-Free Head A's - 2 Vial Ada
Terminated Class III Drugs
- Recall started
- 2 March 2021
- Terminated
- 21 March 2022
- Reason
- Failed pH specifications: Out of Specification pH results for 0.9% Sodium Chloride, USP
- Distribution
- Distributed nationwide in the USA.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-0299-2021
- Menopur 75 IU, (menotropins for injection), packaged as a) 5 single dose vials of Menotropins for injection, 5 single dose vials of 0.9% Sodium Chloride Injection, USP 2 mL, NDC 55566-7501-2; b) Professional Sample Kit:
Terminated Class I Drugs
- Recall started
- 21 July 2020
- Terminated
- 13 October 2023
- Reason
- Superpotent Drug
- Distribution
- Nationwide within the United States.
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-1506-2020, D-1505-2020, D-1504-2020
- STIMATE (desmopressin acetate) Nasal Spray1.5 mg/mL, 2.5 mL glass vial with spray cap, Rx only, Manufactured for: CSL Behring LLC, King of Prussia, PA 19406-0901; By: Ferring GmbH, Kiel, Germany, NDC 0053-6871-00
- Desmopressin Acetate Nasal Spray 10 mcg/0.1 mL, 5mL glass vial with spray cap, Rx only, Manufactured for: AMRING PHARMACEUTICALS INC., Berwyn, PA 19312, NDC 69918-501-05
- DDAVP Nasal Spray (desmopressin acetate) 10 mcg/0.1 mL, 5 mL bottles, Rx Only, Mfd for: Ferring Pharmaceuticals Inc., Parsippany, NJ 07054 USA, NDC 55566-2500-0
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.